This section is dedicated to the E-Rare and all important events related to the research on rare diseases. It is being updated on a weekly basis.
You are here
Home ›The workshop was organized on the 14 of January 2013 in Tel Aviv, Israel by the Chief Scientist Office of the Health Ministry of Israel, a member of E-Rare Consortium.
Recently research in rare diseases has been energized by the rapid expansion of new genomic technologies such as whole exome (WES) and whole genome (WGS) studies to unravel unknown molecular basis of many rare diseases. As a result, researchers are learning more about genetic basis and mechanisms involved in rare diseases, and part of these results is already translated as diagnostic tools for the best benefit of patients.
Importantly, the new generation sequencing approaches generate unequalled amounts of bioinformatics data, which include many known and unknown genetic variants, and among them those that are outside the focus of the study. Thus, these research studies can uncover facts relevant to a volunteer’s/patient’s health, stressing the important question of duty to return individual genetic research results to participants.
This issue has rapidly gained in urgency in view of emerging small and large-scale biobanks as well as the use of collections of biological specimens, and stored genomic data, for research. As a consequence the feasibility of obtaining valid informed consent for research has become even more problematic.
Finally, the creation of genetic databases and biobanks has resulted in numerous national regulations and guidelines to ensure that the interest of patients and of those participating in research programmes is respected. This generated a very heterogeneous landscape across Europe, calling for a need in harmonization of ethical and legal frames for informed consent.
The main Objectives of the Workshop were to:
- Review the nature and content of informed consent for patients with rare diseases in the era of WES and WGS studies
- Capture the European initiatives for harmonizing policies and legal frames for informed consent
The workshop gathered top-level specialists in ethics, law and genome/exome sequencing applied to rare diseases:
Prof. Béla Melegh, Hungary
Prof. Thomas Meitinger, Germany
Prof. Orly Elpeleg, Israel
Prof. Rivka Carmi, Israel
Dr. Vardit Ravitsky, Canada
Prof. Susan Wolf, USA
Adv. Talia Agmon, Israel
Prof. Judit Sandor, Hungary
Prof. Amos Shapira, Israel
Prof. Nils Hoppe, Germany
Dr. Emmanuelle Rial-Sebbag, France
Prof. Ephrat Levy-Lahad, Israel
Dr. Monica Ensini, France
Dr. Simon Woods, UK
Dr. Tessel Rigter, The Netherlands
Looking for collaborations | Contact | Interactive FAQ |
For more information ABOUT E-Rare please contact:
E-Rare Coordinator
Daria JULKOWSKA
Tel.: +33(0) 1 78 09 80 78
+33(0) 6 20 14 13 81
daria.julkowska@agencerecherche.fr
Agence Nationale de la Recherche - ANR
Health & Biology Department
50 Avenue Daumesnil
75012 Paris, France